Nigeria: Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria – the Real Test Is Access

[Nigeria Health Watch] On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. In large trials, twice-yearly lenacapavir delivered near-complete protection against HIV, including zero infections in one major study and very few in another. The guidance brings new momentum to a prevention response that has slowed, but it also raises hard questions about access, equity, and delivery